Your session is about to expire
← Back to Search
Ultrasound Evaluation for Surgery Selection (PUP-VNOTES Trial)
N/A
Recruiting
Led By Aya Mohr-Sasson
Research Sponsored by The University of Texas Health Science Center, Houston
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from operation until one month post-operation
Awards & highlights
No Placebo-Only Group
Summary
This trial studies a minimally invasive surgery done through the vagina. It targets women needing non-cancerous pelvic surgeries but excludes those with severe PID or endometriosis. The technique uses a camera and tools through the vagina to avoid belly cuts, reducing pain and speeding up recovery. This scar-free technique offers shorter hospital stays and lower postoperative pain.
Who is the study for?
This trial is for women who are scheduled to have a hysterectomy or surgery on the ovaries/fallopian tubes and are candidates for vNOTES, a less invasive surgical technique. They should have normal vaginal exams but no history of pelvic radiation, cancer, or current surgeries for prolapse or urinary issues.
What is being tested?
The study tests if using trans-vaginal ultrasound before surgery can help doctors decide better who's fit for vNOTES—a minimally invasive procedure done through the vagina—especially in patients with past infections or endometriosis.
What are the potential side effects?
Since this trial involves an ultrasound evaluation rather than medication, typical drug side effects aren't expected. However, there may be minor discomfort associated with undergoing an ultrasound.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ from operation until one month post-operation
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from operation until one month post-operation
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Secondary study objectives
Organ damage
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Candidates for vaginal natural orifice trans-luminal surgery approachExperimental Treatment1 Intervention
Candidates for benign gynecological surgery in the vaginal natural orifice trans-luminal surgery approach
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Trans-vaginal ultrasound
2014
N/A
~1470
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Pre-operation ultrasound is a critical tool in surgical planning, particularly for procedures like Vaginal Natural Orifice Transluminal Endoscopic Surgery (vNOTES). It helps identify potential adhesions or contraindications, such as those caused by severe pelvic inflammatory disease or endometriosis.
By providing detailed visualization of the pelvic area, ultrasound allows surgeons to select appropriate candidates and plan the procedure more effectively, thereby minimizing surgical risks and improving patient outcomes. This imaging technique ensures that only suitable patients undergo vNOTES, reducing the likelihood of complications and enhancing the overall success of the surgery.
Perioperative focused cardiac ultrasound: a brief report.Cholangiocarcinoma--controversies and challenges.Cardiovascular therapeutic uses of targeted ultrasound contrast agents.
Perioperative focused cardiac ultrasound: a brief report.Cholangiocarcinoma--controversies and challenges.Cardiovascular therapeutic uses of targeted ultrasound contrast agents.
Find a Location
Who is running the clinical trial?
The University of Texas Health Science Center, HoustonLead Sponsor
957 Previous Clinical Trials
347,782 Total Patients Enrolled
3 Trials studying Surgery
204 Patients Enrolled for Surgery
Aya Mohr-SassonPrincipal InvestigatorThe University of Texas Health Science Center, Houston, TX
2 Previous Clinical Trials
190 Total Patients Enrolled
2 Trials studying Surgery
190 Patients Enrolled for Surgery
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have had cancer before.I have had radiation treatment to my pelvic area.I am a woman planning surgery for a hysterectomy or related reason and am considered for a less invasive approach.I am undergoing a vaginal surgery for prolapse or urinary issues.I am a woman scheduled for surgery involving my uterus or ovaries and considered for a less invasive surgical approach.
Research Study Groups:
This trial has the following groups:- Group 1: Candidates for vaginal natural orifice trans-luminal surgery approach
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.